GLAXF   $16.63  -18.93% Market Open

GlaxoSmithKline PLC
Total Cash 2.98B
totalCashPerShare 0.731
EBITDA 10.98B
Total Debt 16.94B
quickRatio 0.529
currentRatio 0.824
Total Revenue 31.45B
debtToEquity 123.043
Revenue/Share 7.736
ROA 0.09557
ROE 0.33299
grossProfits
freeCashflow 5.50B
operatingCashflow 7.48B
earningsGrowth -0.28
revenueGrowth 0.098
grossMargins 0.72776
ebitdaMargins 0.34927
operatingMargins 0.28094998
profitMargins 0.12825
enterpriseValue 100.97B
forwardPE 9.298701
floatShares 3.95B
sharesOutstanding 4.08B
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.02%
heldPercentInstitutions 0.46%
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue 3.523
Price To Book help_outline 6.10
earningsQuarterlyGrowth -0.28
netIncomeToCommon 4.03B
trailingEps 1.47%
forwardEps 2.31%
enterpriseToEbitda 9.19
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.62 3Q 2024
institutionsCount 731
lastUpdated Sept. 16, 2024, 1:41 p.m.